The role of HIF-1 in up-regulating MICA expression on human renal proximal tubular epithelial cells during hypoxia/reoxygenation

BMC Cell Biology

Volumn 11, Issue , 2010, Pages

  Luo, Lei ^a,b   Lu, Jun ^a   Wei, Liang ^a   Long, Dan ^a   Guo, Jia Y ^a   Shan, Juan ^a   Li, Fu S ^a   Lu, Ping Y ^b   Li, Ping Y ^a,b   Feng, Li ^a  

^a Key Laboratory of Transplant Engineering and Immunology of Health Ministry of China   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; GAMMA INTERFERON; HLA A ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HEME OXYGENASE 1; HLA ANTIGEN CLASS 1; MHC CLASS I RELATED CHAIN A; MHC CLASS I-RELATED CHAIN A; VASCULOTROPIN A;

ARTICLE; CELL CULTURE; CELL HYPOXIA; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; NATURAL KILLER CELL; REOXYGENATION; RNA INTERFERENCE; UPREGULATION; CYTOLOGY; EPITHELIUM CELL; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

ADENOVIRIDAE;

CELL HYPOXIA; EPITHELIAL CELLS; HEME OXYGENASE-1; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INTERFERON-GAMMA; KIDNEY TUBULES, PROXIMAL; KILLER CELLS, NATURAL; RNA INTERFERENCE; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 78549270472     PISSN: None     EISSN: 14712121     Source Type: Journal    
DOI: 10.1186/1471-2121-11-91     Document Type: Article

References (35)

1. Sumitran-Holgersson S, Wilczek HE, Holgersson J, Soderstrom K. Identification of the nonclassical HLA molecules, MICA, as targets for humoral immunity associated with irreversible rejection of kidney allografts. Transplantation 2002, 74:268-277. 10.1097/00007890-200207270-00019, 12151741.
2. Sumiltran-Karuppan S, Tyden G, Reinholt F, Berg U, Moller E. Hyperacute rejections of two consecutive renal allografts and early loss of the third transplant caused by non-HLA antibodies specific for endothelial cells. Transpl Immunol 1997, 5:321-327. 10.1016/S0966-3274(97)80016-0, 9504155.
3. Ozawa M, Terasaki PI, Lee JH, Castro R, Alberu J, Alonso C, Alvarez I, Toledo R, Alvez H, Monterio M, Teixeira J, Campbell P, Ciszek M, Charron D, Gautreau C, Christiansen F, Conca R, Gomez B, Monteon F, Grosse-Wilde H, Heinemann F, Humar I, Kamoun M, Kimball P, Kobayashi T, Kupatawintu P, Leech S, LeFor W, Mehra N, Panigrahi A, Naumova E, Norman D, Piazza A, Poli F, Colombo B, Roy R, Schonemann C, Sireci G, Tanabe K, Ishida H, Van den Berg-Loonen E, zeevi A. 14th international HLA and immunogenetics workshop: report on the prospective chronic rejection project. Tissue Antigens 2007, 69(supp.1):174-179. 10.1111/j.1399-0039.2006.00765.x, 17445195.
4. Zou Y, Stastny P, Susal C, Dohler B, Opelz G. Antibodies against MICA antigens and kidney-transplant rejection. N Engl J Med 2007, 357:1293-1300. 10.1056/NEJMoa067160, 17898098.
5. Page Faulk W, Rose M, Meroni PL, Rapa ND, Torry RJ, Labarrere CA, Busing K, Crisp SJ, Dunn MJ, Nelson DR. Antibodies to endothelial cells identify myocardial damage and predict development of coronary artery disease in patients with transplanted hearts. Hum Immunol 1999, 60:826-832. 10.1016/S0198-8859(99)00056-7, 10527389.
6. Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL, Spies T. Activation of NK cells and T cells by NKG2 D, a receptor for stress-inducible MICA. Science 1999, 285:727-729. 10.1126/science.285.5428.727, 10426993.
7. Das H, Groh V, Kuijl C, Sugita M, Morita CT, Sipies T, Bukowski J. MICA engagement by human Vγ2Vδ2 T cells enhances their antigen-dependent effector function. Immunity 2001, 15:83-93. 10.1016/S1074-7613(01)00168-6, 11485740.
8. Suarez-Alvarez B, Lopez-Vazquez A, Baltar JM, Ortega F, Lopez-Larrea C. Potential role of NKG2 D and its ligands in organ transplantation: New target for immunointervertion. AM J Transplant 2009, 9:251-257. 10.1111/j.1600-6143.2008.02526.x, 19178412.
9. Zou Y, Mirbaha F, Lazaro A, Zhang Y, Lavingia B, Stastny P. MICA is a target for complement-dependent cytotoxicity with mouse monoclonal antibodies and human alloantibodies. Hum Immunol 2002, 63:30. 10.1016/S0198-8859(01)00349-4, 11916168.
10. Mizutani K, Terasaki PI, Shih RN, Pei R, Ozawa M, Lee J. Frequency of MIC antibody in rejected renal transplant patients without HLA antibody. Hum Immunol 2006, 67:223-229. 10.1016/j.humimm.2006.02.007, 16698446.
11. Suarez-Alvarez B, Lopez-Vazquez A, Zapico Gonzalez M, Fdez-Morera JL, Diaz-Molina B, Blanco-Gelaz MA, Pascual D, Martinez-Borra J, Muro M, Alvarez-Lopez MR, Lopez-Larrea C. The relationship of anti-MICA antibodies and MICA expression with heart allograft rejection. AM J Transplant 2007, 7:1842-1848. 10.1111/j.1600-6143.2007.01838.x, 17511763.
12. Groh V, Bahram S, Bauer S, Herman A, Beauchamp M, Spies T. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci USA 1996, 93:12445-12450. 10.1073/pnas.93.22.12445, 38011, 8901601.
13. Feng L, Cheng F, Ye Z, Li S, He Y, Yao X, Tang Q, Li Y. The effect of renal ischemia/reperfusion injury on expression of RAE-1 and H60 in mice kidney. Transplant Proc 2006, 38:2195-2198. 10.1016/j.transproceed.2006.06.013, 16980040.
14. Ye Z, Feng L, Huang S, Li S, He Y, Li Y. Expression of H60 on mice heart graft and influence of cyclosporine. Transplant Proc 2006, 38:2168-2171. 10.1016/j.transproceed.2006.06.096, 16980033.
15. Liang W, Jun L, Li F, Shengfu L, Dan L, Juan S, Youping L. Ischemia/Reperfusion Injury Promotes MICA and MICB Expression on Human Cardiac Myocytes Via HIF-1 Pathway. Am J Transplant 2009, (supplement 9):576-577.
16. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003, 3:721-732. 10.1038/nrc1187, 13130303.
17. Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Bio 1992, 12:5447-5454.
18. Wang GL, Jiang BH, Rue EA, Semenza GL. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 1995, 92:5510-5514. 10.1073/pnas.92.12.5510, 41725, 7539918.
19. Lvan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, Salic A, Asara JM, Lane WS, Kaelin WG. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 2001, 292:464-468. 10.1126/science.1059817, 11292862.
20. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Mher ER, Ratcliffe PJ. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999, 399:271-275. 10.1038/20459, 10353251.
21. Jaakkola P, Mole DR, Tian Y, Wilson MI, Gielbert J, Gaskell SJ, Alexander VK, Hebestreit HF, Mukherji M, Schofield CJ, Maxwell PH, Pugh CW, Ratcliffe PJ. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 2001, 292:468-472. 10.1126/science.1059796, 11292861.
22. Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 1992, 12:5447-5454. 360482, 1448077.
23. Huang LE, Gu J, Schau M, Bunn HF. Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 1998, 95:7987-7992. 10.1073/pnas.95.14.7987, 20916, 9653127.
24. Elson DA, Thurston G, L EH, Ginzinger DG, Mcdonald DM, Johnson RS, Arbeit JM. Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1alpha. Genes Dev 2001, 15:2520-2532. 10.1101/gad.914801, 312791, 11581158.
25. Forsythe JA, Jiang BH, Lyer NV, Agani F, Leung SW, Koos RD, Semenza GL. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 1996, 16:4604-4613. 231459, 8756616.
26. Lee PJ, Jiang BH, Chin BY, Lyer NV, Alam J, Semenza GL, Choi AMK. Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia. J Biol Chem 1997, 272:5375-5381. 10.1074/jbc.272.9.5375, 9038135.
27. Jassem W, Heaton ND. The role of mitochondria in ischemia/reperfusion injury in organ transplantation. Kidney Int 2004, 66:514-517. 10.1111/j.1523-1755.2004.761_9.x, 15253700.
28. Hellwig-Burgel T, Stiehl DP, Wagner AE, Metzen E, Jelkmann W. Review: hypoxia-inducible factor-1 (HIF-1): a novel transcription factor in immune reactions. J Interferon Cytokine Res 2005, 25:297-310. 10.1089/jir.2005.25.297, 15957953.
29. Stastny P. Introduction: MICA/MICB in innate immunity adaptive immunity, autoimmunity, cancer, and in the immune response to transplants. Hum Immunol 2006, 67:141-144. 10.1016/j.humimm.2006.02.019, 16698435.
30. Terasaki PI, Ozawa M, Castro R. Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival. Am J Transplant 2007, 7:408-415. 10.1111/j.1600-6143.2006.01644.x, 17229080.
31. Zwirner NW, Marcos CY, Mirbaha F, Zou Y, Stastny P. Identification of MICA as a new polymorphic alloantigen recognized by antibodies in sera of organ transplant recipients. Hum Immunol 2000, 61:917-924. 10.1016/S0198-8859(00)00162-2, 11053635.
32. Suarez-Alvarez B, Lopez-vazquez A, Baltar JM, Ortega F, Lopez-Larrea C. Potential role of NKG2 D and its ligands in organ transplantation: new target for immunointervention. Am J Transplant 2009, 9:251-257. 10.1111/j.1600-6143.2008.02526.x, 19178412.
33. Kawasaki A, Shinkai Y, Yagita H, Okumura K. Expression of perforin in murine natural killer cells and cytotoxia T lymphocytes in vivo. Eur J Immunol 1992, 22:1215-1219. 10.1002/eji.1830220516, 1577064.
34. Semenza GL, Jiang BH, Leung SW, Passantino R, Concordet JP, Maire P, Giallongo A. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem 1996, 271:32529-37. 10.1074/jbc.271.51.32529, 8955077.
35. Liang W, Jun L, Li F, Shengfu L, Juan S, Youping L. Construcion of recombinant adenovirus vector containing a modified gene that codes for human hypoxia-inducible factor-1alpha without oxygen-dependent degradation domain. Plasmid 2010, 63:20-26. 10.1016/j.plasmid.2009.09.002, 19766670.